Similar ceRNA-driven mechanisms involving miR-376a-3p/YAP1 in glioma, miR-590-5p/METTL3 in lung adenocarcinoma, and miR-376a-3p/PRMT5 in prostate cancer further underscore its oncogenic potential. The gene discussed is PRMT5; the disease is central nervous system cancer.